share_log

【华安证券】双成药业:新股点评

[Huaan Securities] Shuangcheng Pharmaceutical Co., Ltd.: comments on New shares

華安證券 ·  Aug 8, 2012 00:00  · Researches

It is estimated that the EPS of the company from 2012 to 2014 is 0.70,0.82 and 0.95 yuan respectively.

At present, the average dynamic price-to-earnings ratio of the comparable company in 2012 is 25-30 times; considering the slowdown in the growth rate caused by the company's production capacity restrictions in the past two years, we think the price of the stock may be 18-25 yuan after listing.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment